The method of embodiment 127, wherein the at least one viscosity modulating agent is silicon dioxide, povidone, carbomer, poloxamer, or a combination thereof
As of January 1, 2025, 25% of Alzheimer's clinical trials registered with clinicaltrials.gov addressed cognitive and neuropsychiatric symptoms of Alzheimer's
Combining X39 with Other LifeWave Products Using X39 with other LifeWave products can create even better results
Understanding how to manage and lower blood pressure
Low levels of this amino acid can impair your cognition, including your memory of events or experiences
Patients should follow specific storage instructions provided with their medication and never freeze or expose peptides to extreme temperatures